| Biotechnology Industry | Healthcare Sector | Steven Bryan Warnecke CEO | OTCQB Exchange | 30051F101 CUSIP |
| US Country | 2 Employees | - Last Dividend | 19 Oct 2015 Last Split | - IPO Date |
Evolutionary Genomics, Inc., situated in Castle Rock, Colorado, operates at the forefront of genetic research with a focus on positively selected genes across humans, animals, and commercial crops. By leveraging its subsidiaries’ capabilities, the company ventures into identifying genes that play key roles in various biological traits and adaptations. This initiative underpins its commitment to service the broad spectrum of clients that include governmental organizations, non-profit foundations, and commercial entities. Through its expansive research and innovative approaches, Evolutionary Genomics strives to uncover the genetic foundations that can be harnessed to address contemporary challenges in agriculture, health, and environmental sustainability.
This technological platform represents the company’s core initiative to revolutionize the field of agricultural biotechnology. By identifying genes that contribute to critical agricultural traits such as yield enhancement, sugar content augmentation, increased biomass, improved drought tolerance, and enhanced resistance to pests and diseases, the Adapted Traits Platform paves the way for developing crop plants that are not only more productive but also more resilient to the challenges posed by climate change and environmental degradation. This platform serves as a beacon of hope for increasing food security and sustainability in agricultural practices worldwide.